Top

Published in:

01-11-2006 | Original

Outcome in bacteremia associated with nosocomial pneumonia and the impact of pathogen prediction by tracheal surveillance cultures

Authors: Pieter Depuydt, Dominique Benoit, Dirk Vogelaers, Geert Claeys, Gerda Verschraegen, Koenraad Vandewoude, Johan Decruyenaere, Stijn Blot

Published in: Intensive Care Medicine | Issue 11/2006

Abstract

Objective

To assess whether pathogen prediction in bacteremia associated with nosocomial pneumonia (NP) by tracheal surveillance cultures improves adequacy of early antibiotic therapy and impacts mortality.

Design and setting

A retrospective observational study of a prospectively gathered cohort. This cohort included all adult patients admitted to the ICU of a tertiary care hospital from 1992 through 2001 and who developed bacteremia associated with NP.

Measurements and main results

128 episodes of bacteremia associated with NP were identified. In 110 episodes a tracheal surveillance culture 48–96 h prior to bacteremia was available: this culture predicted the pathogen in 67 episodes (61%). Overall rates of appropriate empiric antibiotic therapy within 24 and 48 h were 62 and 87%, respectively. Pathogen prediction was associated with a significantly higher rate of appropriate antibiotic therapy within 24 h (71 vs 45%; p = 0.01), but not within 48 h (91 vs 82%; p = 0.15). Crude in-hospital mortality was 50%. Pathogen prediction was associated with increased survival in univariate (OR 0.43; CI 0.19–0.93; p = 0.04) and multivariate analysis (OR 0.32; CI 0.12–0.82; p = 0.02). Multivariate analysis further identified age (OR 1.04; CI 1.01–1.07; p = 0.02), increasing APACHE II score (OR 1.08; CI 1.02–1.15; p = 0.01), and methicillin-resistant Staphylococcus aureus (OR 5.90; CI 1.36–25.36; p = 0.01) and Pseudomonas aeruginosa (OR 3.30; CI 1.04–10.4; p = 0.04) as independent risk factors for mortality.

Conclusion

Pathogen prediction in bacteremia associated with NP by tracheal surveillance cultures is associated with a higher rate of adequate empiric antibiotic therapy within 24 h and with increased survival.

Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolaschanoin MH, Wolff M, Spencer RC, Hemmer M (1995) The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) Study. J Am Med Assoc 274:639–644CrossRef

National Nosocomial Infections (NNIS) system (2001) Data summary from Jan 1992-June 2001. Am J Infect Control 29:408–421

Vincent JL (2003) Nosocomial infections in adult intensive-care units. Lancet 361:2068–2077PubMedCrossRef

Hernandez G, Rico P, Diaz E, Rello J (2004) Nosocomial lung infections in adult intensive care units. Microbes and Infection 6:1004–1014PubMedCrossRef

Rello J, Rue M, Jubert P, Muses G, Sonora R, Valles J, Niederman MS (1997) Survival in patients with nosocomial pneumonia: impact of the severity of illness and the etiologic agent. Crit Care Med 25:1862–1867PubMedCrossRef

Rello J, Jubert P, Valles J, Artigas A, Rue M, Niederman MS (1996) Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa. Clin Infect Dis 23:973–978PubMed

Fagon J, Chastre J, Hance AJ, Montravers P, Novara A, Gibert C (1993) Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 94:281–288PubMedCrossRef

Rello J, Torres A, Ricart M, Valles J, Gonzalez J, Artigas A, Rodriguezroisin R (1994) Ventilator-associated pneumonia by Staphylococcus aureus: comparison of methicillin-resistant with methicilline sensitive episodes. Am J Respir Crit Care Med 150:1545–1549PubMed

Luna CM, Vujacich P, Niederman M, Vay C, Gherardi C, Matera J, Jolly EC (1997) Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 111:676–685PubMed

10.

Rello J, Gallego M, Mariscal D, Sonora R, Valles J (1997) The value of routine microbiological investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med 156:196–200PubMed

11.

Kollef M, Ward S (1998) The influence of mini-BAL cultures on patient outcome: Implications for the antibiotic management of ventilator-associated pneumonia. Chest 113:412–420PubMed

12.

Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH (2002) Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 122:262–268PubMedCrossRef

13.

Wunderink R (1993) Mortality and ventilator-associated pneumonia. The best antibiotics may be the least antibiotics. Chest 104:993–995PubMed

14.

Fridkin S, Gaynes R (1999) Antimicrobial resistance in intensive care units. Clin Chest Med 20:303–316PubMedCrossRef

15.

Höffken G, Niederman M (2002) Nosocomial pneumonia: the importance of a de-escalation strategy for antibiotic treatment of pneumonia in the ICU. Chest 122:2183–2196PubMedCrossRef

16.

Paterson D, Rice L (2003) Empirical antibiotic choice for the seriously ill patient: Are minimization of selection of resistant organisms and maximization of individual outcome mutually exclusive? Clin Infect Dis 36:1006–1012PubMedCrossRef

17.

Rello J, Vidaur L, Sandiumenge A, Rodriguez A, Gualis B, Boque C, Diaz E (2004) De-escalation therapy in ventilator-associated pneumonia. Crit Care Med 32:2183–2190PubMed

18.

Blot S, Depuydt P, Vogelaers D, Decruyenaere J, De Waele J, Hoste E, Peleman R, Claeys G, Verschraegen G, Colardyn F, Vandewoude K (2005) Colonization status and appropriate antibiotic therapy in nosocomial bacteremia caused by antibiotic-resistant Gram-negative bacteria in the ICU. Infect Control Hosp Epidemiol 26:575–579PubMedCrossRef

19.

Depuydt P, Blot S, Benoit D, Claeys G, Verschraegen G, Vandewoude K, Vogelaers D, Decruyenaere J, Colardyn F (2006) Antimicrobial resistance in nosocomial blood stream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit. Crit Care Med 34:653–659PubMedCrossRef

20.

Depuydt P, Blot S, Benoit D, Vogelaers D, Claeys G, Verschraegen G, Vandewoude K, Decruyenaere J, Blot S (2005) Outcome in bacteremic nosocomial pneumonia and the value of regular tracheal surveillance cultures. Program and abstracts of the 45th ICAAC (Interscience Conference on Antimicrobial Agents and Chemotherapy), Washington, A299

21.

Charlson M, Pompei P, Ales K, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383PubMedCrossRef

22.

Carmeli Y, Troillet N, Eliopoulos GM, Samore MH (1999) Emergence of antibiotic-resistant Pseudomonas aeruginosa. Comparison of risks associated with different antipseudomonal agents. Antimicrob Agents Chemother 43:1379–1382PubMed

23.

Blot S, Vandewoude K, De Bacquer D, Colardyn F (2002) Nosocomial bacteremia caused by antibiotic-resistant Gram-negative bacteria in critically ill patients: clinical outcome and length of hospitalization. Clin Infect Dis 34:1600–1606PubMedCrossRef

24.

NCCLS (2003) Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A8. Wayne

25.

Blot S, Vandewoude K, Colardyn F (2000) Prevalence and risk factors for colonisation with Gram-negative bacteria in an intensive care unit. Acta Clin Belg 55:249–256PubMed

26.

Murray P, Barron E, Jorgensen J, Pfaller M, Yolken R (eds) (2003) Manual of clinical microbiology, 8th edn. ASM Press, Washington, DC

27.

Rello J, Diaz E (2003) Pneumonia in the intensive care unit. Crit Care Med 31:2544–2551PubMedCrossRef

28.

Alvarez-Lerma F for the ICU-Acquired Pneumonia Study Group (1996) Modifications of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. Intensive Care Med 22:387–394PubMedCrossRef

29.

Blot S, Vandewoude K (2004) Early detection of systemic infections. Acta Clin Belg 59:20–23PubMed

30.

Fagon JY, Chastre J, Wolff M, Gervais C, Parer-Aubas S, Stephan F, Similowski T, Mercat A, Diehl JL, Sollet JP, Tenaillon A (2000) Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia: a randomized trial. Ann Intern Med 132:621–630PubMed

31.

Brun-Buisson C, Fartoukh M, Lechapt E, Honore S, Zahar JR, Cerf C, Maitre B (2005) Contribution of blinded, protected quantitative specimens to the diagnostic and therapeutic management of ventilator-associated pneumonia. Chest 128:533–544PubMedCrossRef

32.

Colardyn F (2005) Appropriate and timely empirical antimicrobial treatment of ICU infections: a role for carbapenems. Acta Clin Belg 60:51–62PubMed

33.

Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH (2000) The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118:146–155PubMedCrossRef

34.

Dupont H, Montravers P, Gauzit M, Veber B, Pouriat JL, Martin C (2003) Outcome of postoperative pneumonia in the Eole study. Intensive Care Med 29:179–188PubMed

35.

Kollef M, Sherman G, Ward S, Fraser VJ (1999) Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115:462–474PubMedCrossRef

36.

American Thoracic Society (2005) Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and health-care associated pneumonia. Am J Respir Crit Care Med 171:388–416CrossRef

37.

Blot S, Vandewoude K, Hoste E, Colardyn F (2002) Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med 162:2229–2235PubMedCrossRef

38.

Combes A, Luyt CE, Fagon JY, Wolff M, Trouillet JL, Gibert C, Chastre J (2004) Impact of methicillin resistance on outcome of Staphylococcus aureus ventilator-associated pneumonia. Am J Respir Crit Care Med 170:786–792PubMedCrossRef

39.

Wunderink R, Rello J, Cammarata S, Croos-Dabrera R, Kollef MH (2003) Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest 124:1789–1797PubMedCrossRef

40.

Niederman M (2001) Impact of antibiotic resistance on clinical outcomes and the cost of care. Crit Care Med(Suppl):S114–S120

41.

Hayon J, Figliolini C, Combes A, Trouillet JL, Kassis N, Dombret MC, Gibert C, Chastre J (2002) Role of serial routine microbiologic culture results in the initial management of ventilator-associated pneumonia. Am J Respir Crit Care Med 165:41–46PubMed

42.

Bouza E, Perez A, Munoz P, Perez J, Rincon C, Sanchez C, Martin-Rabadan P, Riesgo M (2003) Ventilator-associated pneumonia after heart surgery: a prospective analysis and the value of surveillance. Crit Care Med 31:1964–1970PubMedCrossRef

43.

Crnich C, Proctor R (2003) Ventilator-associated pneumonia: Does surveillance have a role in its management. Crit Care Med 31:2411–2412PubMedCrossRef

44.

Michel F, Franceschini B, Berger P, Arnal JM, Gainnier M, Sainty JM, Papazian L (2005) Early antibiotic treatment for BAL-confirmed ventilator-associated pneumonia: a role for routine endotracheal aspirate cultures. Chest 127:589–597PubMedCrossRef

45.

Houck PM, Bratzler DW, Nsa W, Ma A, Bartlett JG (2004) Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 164:637–644PubMedCrossRef

46.

Kumar A, Roberts D, Wood K, Light B, Parillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in septic shock. Crit Care Med 34:1589–1596PubMedCrossRef

47.

Calandra T, Cohen J (2005) The International Sepsis Forum Consensus Conference on Definitions of Infection in the Intensive Care Unit. Crit Care Med 33:1538–1548PubMedCrossRef

48.

Bryan CS, Reynolds KL (1984) Bacteremic nosocomial pneumonia. Analysis of 172 episodes from a single metropolitan area. Am Rev Respir Dis 129:668–671PubMed

Title: Outcome in bacteremia associated with nosocomial pneumonia and the impact of pathogen prediction by tracheal surveillance cultures
Authors: Pieter Depuydt
Dominique Benoit
Dirk Vogelaers
Geert Claeys
Gerda Verschraegen
Koenraad Vandewoude
Johan Decruyenaere
Stijn Blot
Publication date: 01-11-2006
Publisher: Springer-Verlag
Published in: Intensive Care Medicine / Issue 11/2006
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-006-0354-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Outcome in bacteremia associated with nosocomial pneumonia and the impact of pathogen prediction by tracheal surveillance cultures

Abstract

Objective

Design and setting

Measurements and main results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Design and setting

Measurements and main results

Conclusion

Please log in to get access to this content

Other articles of this Issue 11/2006

Validation of the SAPS 3 admission prognostic model in patients with cancer in need of intensive care

Benefits and risks of success or failure of noninvasive ventilation

Increased colorectal permeability in patients with severe sepsis and septic shock

Genetic variation and the assessment of risk in septic patients

Unveiling alveolar recruitment: the fascinating trail between theory and practice

A good death: another break in the wall